Cargando…

Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

BACKGROUND: Cardiovascular magnetic resonance imaging (CMR) have described localised non-ischemic late gadolinium enhancement (LGE) lesions of prognostic importance in various non-ischemic cardiomyopathies. Ischemic LGE lesions are prevalent in diabetes (DM), but non-ischemic LGE lesions have not pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bojer, Annemie Stege, Sørensen, Martin Heyn, Vejlstrup, Niels, Goetze, Jens P., Gæde, Peter, Madsen, Per Lav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583253/ https://www.ncbi.nlm.nih.gov/pubmed/33092588 http://dx.doi.org/10.1186/s12933-020-01160-y

Ejemplares similares

Left Ventricular Diastolic Function Studied with Magnetic Resonance Imaging: A Systematic Review of Techniques and Relation to Established Measures of Diastolic Function
por: Bojer, Annemie Stege, et al.
Publicado: (2021)

Conductance artery stiffness impairs atrio-ventriculo-arterial coupling before manifestation of arterial hypertension or left ventricular hypertrophic remodelling
por: Kyhl, Kasper, et al.
Publicado: (2021)

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
por: Sørensen, Martin H., et al.
Publicado: (2020)

The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study
por: Bojer, Annemie S., et al.
Publicado: (2023)

Longitudinal shortening of sub‐epicardial myocytes in severe ischaemic cardiomyopathy: insights from gadolinium contrast cardiac magnetic resonance imaging
por: Bjerre, Jenny, et al.
Publicado: (2017)

Cardiac function and incidence of unexplained myocardial scarring in patients with primary carnitine deficiency - a cardiac magnetic resonance study
por: Kyhl, Kasper, et al.
Publicado: (2019)

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
por: Thirumathyam, Roopameera, et al.
Publicado: (2022)

Long‐Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow‐Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging
por: Ersbøll, Anne S., et al.
Publicado: (2018)

Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation
por: Şimşek, Evrim, et al.
Publicado: (2016)

Verification of threshold for image intensity ratio analyses of late gadolinium enhancement magnetic resonance imaging of left atrial fibrosis in 1.5T scans
por: Bertelsen, Litten, et al.
Publicado: (2019)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Dark blood Late Gadolinium Enhancement improves conspicuity of ablation lesions
por: Kellman, Peter, et al.
Publicado: (2016)

Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non‐ischemic cardiomyopathy
por: Ota, Shingo, et al.
Publicado: (2021)

Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
por: Doltra, Adelina, et al.
Publicado: (2013)

Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
por: Shah, Dr. Viraj, et al.
Publicado: (2022)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2015)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Prediction of gaps in atrial ablation lesion sets by late gadolinium enhancement magnetic resonance imaging
por: Harrison, James, et al.
Publicado: (2013)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Incidence, Clinical Significance, and Longitudinal Signal Characteristics of Ischemic Lesions Related to Diagnostic Cerebral Catheter Angiography
por: Schinz, David, et al.
Publicado: (2023)

Acute anterior myocardial infarction seen on conventional iodine-contrast CT
por: Hagdrup, Christian, et al.
Publicado: (2017)

Quantification of myocardial late gadolinium enhancement using synthetic inversion recovery imaging
por: Varga-Szemes, Akos, et al.
Publicado: (2015)

Clinical predictors for the manifestation of late gadolinium enhancement after acute myocardial infarction
por: Abanador-Kamper, Nadine, et al.
Publicado: (2017)

What is the mid-wall linear high intensity “lesion” on cardiovascular magnetic resonance late gadolinium enhancement?
por: Nakamura, Masashi, et al.
Publicado: (2020)

Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women’s Interagency HIV Study
por: Kato, Yoko, et al.
Publicado: (2021)

Equivalence of conventional and fast late gadolinium enhancement (LGE) techniques for quantitative evaluation of fibrosis in ischemic and non-ischemic cardiac disease - Save the Time!
por: Muehlberg, Fabian, et al.
Publicado: (2016)

Detection and prevalence of myocardial infarction early and late after heart transplantation detected by late gadolinium enhanced MRI
por: Steen, Henning, et al.
Publicado: (2012)

Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016)

Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
por: Wexberg, Paul, et al.
Publicado: (2016)

Relationship of Myocardial Gadolinium Enhancement to Late Clinical Outcomes: Implications for the COVID-19 era
por: Morris, Paraskevi, et al.
Publicado: (2022)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qkivfn3ao86l58pjeqjuv1aq7v